Arvinas (ARVN) Stock: Buy, Sell, or Hold?
$6.92
+0.16 (+2.37%)
â˛
5d:
-2.4%
30d:
-7.11%
90d:
-21.98%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 03, 2026
0d
Protect ARVN Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (67%)
Quality Score
46/100
Position
SLIGHTLY LOW
30-Day Fair Range
$6.91 â $7.67
Position: SLIGHTLY LOW
Forward P/E & Valuation
-2.2x
Next 12M consensus est.
Wall Street Target
$14.00
+102.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.33 / $8.03
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: ARVN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When ARVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ARVN is currently trading at $6.92, which is considered slightly low relative to its 30-day fair value range of $6.91 to $7.67.
Technical Outlook: Technically, ARVN is in a downtrend. Immediate support is located at $6.33, while resistance sits at $8.03.
Market Sentiment: ARVN scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.00 (+102.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARVN is in a downtrend. Immediate support is located at $6.33, while resistance sits at $8.03.
Market Sentiment: ARVN scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.00 (+102.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.91 -
$7.67
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
Trading Range & Key Levels
30-Day Trading Range
$6.91 -
$7.67
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Âą$0.59
(8.5%)
Support Level
$6.33
Resistance Level
$8.03
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding ARVN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 102.3% below Wall St target ($14.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.18
Wall Street Target
$14.00
(+102.3%)
Revenue Growth (YoY)
-98.8%
Profit Margin
-3.5%
Share ARVN Analysis
Share this live ARVN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ARVN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Arvinas is presenting preliminary clinical data from the Phase 1 study of ARV-393 (zaloblideg), an oral PROTAC BCL6 degrader, at the 2026 American Society of Hematology (ASH) Annual Meeting. The data will include safety, pharmacokinetics, and pharmacodynamics from all patients, with preliminary efficacy from patients with T-cell lymphomas.
Key Retail Themes:
Clinical trial data
ASH Annual Meeting
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:35 AM ET
Data refreshes hourly during market hours. Next update: 6:35 AM
Data refreshes hourly during market hours. Next update: 6:35 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Advanced ARVN Option Strategies
Professional options setups generated by AI based on today's ARVN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ARVN Research Pages
